Physician profile
Beth A Ryan
NPI 1194059212
$3,199.19
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $936 · 2022: $901 · 2023: $912 · 2024: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,362.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $639.31 | 2021-2024 | |
| Lilly USA, LLC | $566.21 | 2021-2024 | Mounjaro, Trulicity, Zepbound |
| Novo Nordisk INC | $538.73 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $500.11 | 2021-2024 | Breztri, Farxiga |
| Glaxosmithkline, LLC. | $321.07 | 2021-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.70 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $67.15 | 2021-2023 | |
| Daiichi Sankyo INC. | $66.42 | 2021 | |
| Abbott Laboratories | $59.11 | 2022-2023 | Freestyle Libre 3 |
| Genzyme Corporation | $54.28 | 2021-2023 | |
| Teva Pharmaceuticals USA, INC. | $52.18 | 2022-2023 | Airduo Digihaler |
| Amgen INC. | $45.69 | 2024 | Krystexxa |
| Horizon Therapeutics Plc | $37.24 | 2023 | Krystexxa |
| Merck Sharp & Dohme LLC | $32.61 | 2022-2023 | Verquvo, Belsomra |
| Pfizer INC. | $30.14 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $25.00 | 2022 | |
| Tactile Systems Technology INC | $20.27 | 2023 | Entre Plus, Flexitouch Plus |
| Sanofi Pasteur INC. | $20.25 | 2024 | |
| Medtronic, INC. | $16.44 | 2022 | |
| Exact Sciences Corporation | $14.45 | 2024 | Cologuard Collection Kit |
| Electronic Waveform Lab, INC. | $13.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.